Dr. Pepper Snapple
numbers cut at Morgan Stanley. Shares now seen reaching $29. Estimates also lowered ahead of earnings. Equal-weight rating.
target cut at Credit Suisse to $26 from $30 based on tougher than expected outlook outlined by management. Maintained Neutral rating.
(MO - Get Report)
numbers cut at Morgan Stanley. Equal-weight rating and new $22 price target.
price target cut at Goldman to $5 from $5.50 following lower than expected Q3 results. Note that company has had to constrain capital expenditures to protect cash flow as margins have declined. Maintained Neutral rating.
price target reduced at Goldman to $23 from $26 to reflect weaker fundamentals and strong U.S. dollar currency moves. Believe premium valuation will continue to deteriorate as guest counts remain in decline. Maintained Sell rating.
estimates raised, target cut at Morgan Stanley. Shares of URS now seen reaching $55. Estimates raised however. Overweight rating.
Strategy Calls/Market Calls
downgraded from Buy to Hold, Deutsche Bank said. Companies face several risks, and earnings expectations have likely yet to bottom.